Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,378.0
16.9 (0.50%)

 

  • STI Straits Times Index
    3,378.0
    16.9 (0.50%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,658.2
    9.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,765.4
    303.7 (1.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,924.2
    23.0 (0.79%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,467.0
    420.8 (2.00%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,456.5
    53.2 (0.83%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,094.4
    27.8 (1.35%)
    Index delayed 20 minutes
  • XAO XAO
    6,786.2
    50.8 (0.75%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 951.8M
  • Value: 1,059.6M
  • Rise: 198
  • Fall: 120
  • Unch: 520

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Libra0.052+0.025
QT Vascular0.006+0.002
Sino Grandness0.050+0.004
SunMoonFood^0.063+0.005
Koh Eco0.058+0.001
G Invacom^0.137+0.005
Genting Sing0.920-
Sen Yue0.038-
Golden Agri-Res0.300-
TEE Intl0.102+0.001

World Indices

World Indices
Name Last Change
Nasdaq 8,146.5 -60.8
HSI 28,765.4 +303.7
HSCEI 10,909.4 +124.9
Jakarta 6,456.5 +53.2
Nikkei 225 21,467.0 +420.8
SSE Comp 2,924.2 +23.0
Shanghai A 3,062.8 +24.1
Shanghai B 290.0 +1.3
ShenZhen A 1,631.7 +12.2
ShenZhen B 972.3 +3.6
Taiwan W 10,873.2 +73.9
PSE Comp 0.0
KOSPI 2,094.4 +27.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

3SBIO 3SBIO
Quotes 15 Minutes Delayed. Updated at 19 Jul 2019 16:08
Last (HKD): 13.600 Change: +0.060 High: 13.840 Remarks: -
Change (%): +0.44 Low: 13.500
Open 13.600 Yesterday's Close 13.540
Buy Price 13.580 Sell Price 13.600
Buy Volume ('000) 45.5 Sell Volume ('000) 29.5
Cumulative Volume ('000) 5,439.311 Cumulative Value 74,378,009
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.59778 Trailing EPS (HKD) e 0.59778 NAV (HKD) b 3.8819
PE a 22.751 Trailing PE f 22.751 Price / NAV b 3.5034
Dividend (HKD) d - Cash In Hand (HKD) g 0.8142 Issued & Paid-up Shares c 2,530,620,000
Dividend Yield (%) d - Price / Cash In Hand g 16.704 Treasury Shares h 4,370,000
Beta - 75 Daysi 1.565 R-Squared - 75 Days(%)i 36.21 Market Cap (M) 34,416.432
Beta - 500 Daysi 1.261 R-Squared - 500 Days (%)i 21.13 Enterprise Value (M) 36,449.982
Piotroski F Score 5 Exchange Code 1530 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 46.43 6-Month VWAP 13.686 Free Float (%) 49.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Jun 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 3SBIO HKEx 34,416.432 22.751 22.751 3.5034 -
Industry Biotechnology HKEx 49,664.696 13.215 13.813 5.6269 2.736
Local Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Local Peer SINO BIOPHARM HKEx 112,772.358 10.525 10.803 3.2534 0.816
Local Peer WUXI BIO HKEx 101,735.436 136.210 136.209 11.1604 -
Local Peer BEIGENE HKEx 58,192.327 - - 4.6079 -
Local Peer GENSCRIPT BIO HKEx 34,034.889 204.675 204.683 9.0819 -
Local Peer HAOHAI BIOTEC HKEx 7,586.147 15.450 15.450 1.8420 -
Local Peer FRONTAGE HKEx 6,886.205 78.168 78.162 20.1528 -
Local Peer VIVA BIOTECH HKEx 6,799.727 63.402 63.399 23.7194 -
Local Peer ASCLETIS-B HKEx 6,320.692 - - 1.6172 -
Local Peer CKLIFE SCIENCES HKEx 4,132.760 15.716 15.714 0.9693 2.326
Local Peer ESSEX BIO-TECH HKEx 4,051.649 17.532 17.533 4.3616 -
Local Peer LEE'S PHARM HKEx 3,068.161 7.335 7.335 1.3880 2.277
Other Local Peers BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 108,806.483 12.962 13.474 10.0449 3.055
Global Peer GILEAD SCIENCES INC NASDAQ 82,702.262 15.161 14.036 3.7676 3.534
Global Peer CSL ASX 101,856.584 45.649 41.810 14.7785 1.014
Global Peer CELGENE CORP NASDAQ 63,614.452 15.723 13.407 7.7911 -
Global Peer BIOGEN INC NASDAQ 44,841.634 10.121 9.609 3.2424 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,598.350 21.274 20.697 9.4422 -
Global Peer ILLUMINA INC NASDAQ 43,100.400 52.180 50.647 10.8157 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,684.289 13.371 13.464 3.4606 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,087.830 349.072 65.052 2.7907 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 21,708.719 68.699 19.435 4.2359 0.873
Other Global Peers INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MODERNA INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), TILRAY INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ACCELERON PHARMA (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), NATERA INC (NASDAQ), REGENXBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RETROPHIN INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARVINAS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), STOKE THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), OMEROS CORP (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), LEXICON PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SYNTHORX INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), KARYOPHARM THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), NEXT SCIENCE LTD (ASX), GLYCOMIMETICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), RESTORBIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), MERUS B V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), KADMON HLDGS INC (NYSE), SORRENTO THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), CONCERT PHARMACEUTICALS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), GERON CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), CALITHERA BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), MANNKIND CORPORATION (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), AFFIMED N V (NASDAQ), CHIMERIX INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), NABRIVA THERAPEUTICS PLC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ENZO BIOCHEM INC (NYSE), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PFENEX INC (NYSE American), DYADIC INTERNATIONAL INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), TOCAGEN INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SESEN BIO INC (NASDAQ), BIOTIME INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NANTKWEST INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), VERASTEM INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), NEON THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), EQUILLIUM INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SAVARA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PORT (SET), ALPINE IMMUNE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), INFLARX N V (NASDAQ), OTONOMY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CURIS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), FENNEC PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ORGENESIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), IBIO INC (NYSE American), COHBAR INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), ARAVIVE INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORTHOCELL LIMITED (ASX), VACCINEX INC (NASDAQ), PHYLOGICA LIMITED (ASX), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), IMUGENE LIMITED (ASX), ZAFGEN INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ZELDA THERAPEUTICS LTD (ASX), EVOGENE LTD (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOTRON (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), SENESTECH INC (NASDAQ), RHINOMED LIMITED (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), AETERNA ZENTARIS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), AZURRX BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ADALTA LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), BIOCEPT INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CO DIAGNOSTICS INC (NASDAQ), HISTOGENICS CORP (NASDAQ), PATRYS LIMITED (ASX), PRECIPIO INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), VICAL INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), BIONOMICS LTD (ASX), NANOVIRICIDES INC (NYSE American), OHR PHARMACEUTICAL INC (NASDAQ), IMMURON LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES (ASX), REGENEUS LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLMID LIMITED (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), TROVAGENE INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), VAXART INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONATUS PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City^ (SGX), ANATARA LIFESCIENCES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), BIOXYNE LIMITED (ASX), ADVAXIS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), QT Vascular (SGX), ARCA BIOPHARMA INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), ACTINOGEN MEDICAL LTD (ASX), MGRC (Bursa), MEGASUN (Bursa), NEURALSTEM INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), OPGEN INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), CYTORI THERAPEUTICS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), MEDIBIO LIMITED (ASX), NANOLLOSE LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX), SINOVAC BIOTECH (NASDAQ), ALCHEMIA LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.100
+0.74 %
10 Days --0.500
-3.55 %
20 Days -+0.460
+3.50 %
Medium Term Return 3 Months --1.920
-12.37 %
6 Months -+1.020
+8.11 %
1 Year --4.860
-26.33 %
Long Term Return 2 Years 0.069+4.040
+42.98 %
3 Years 0.069+5.640
+71.72 %
Annualised Return Annualised --
+19.75 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.210 - 18.800 Change From 1 Year Low +5.390 % Change From 1 Year Low (%) +65.65
Change From 1 Year High -5.200 % Change From 1 Year High (%) -27.66
2 Years Range 8.210 - 23.250 Change From 2 Years Low +5.390 % Change From 2 Years Low (%) +65.65
Change From 2 Years High -9.650 % Change From 2 Years High (%) -41.51
5 Years Range 6.900 - 23.250 Change From 5 Years Low +6.700 % Change From 5 Years Low (%) +97.10
Change From 5 Years High -9.650 % Change From 5 Years High (%) -41.51
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.

Historical Price Data

Date Open High Low Close Volume VWAP
19 Jul 2019 13.600 13.840 13.500 13.600 5,439,311 13.6742
18 Jul 2019 13.360 13.980 13.360 13.540 5,040,000 13.5354
17 Jul 2019 13.720 14.100 13.720 13.980 5,050,369 13.9897
16 Jul 2019 13.860 13.960 13.820 13.880 5,011,690 13.8862
15 Jul 2019 13.500 13.880 13.220 13.880 8,183,372 13.6428
12 Jul 2019 14.020 14.140 13.380 13.500 9,481,500 13.5736
11 Jul 2019 14.180 14.360 14.040 14.200 2,798,668 14.1935
10 Jul 2019 13.840 14.260 13.840 14.160 7,743,000 14.0989
09 Jul 2019 13.800 13.820 13.340 13.720 2,686,000 13.5891
08 Jul 2019 14.100 14.280 13.640 13.800 4,701,500 14.1564
05 Jul 2019 14.420 14.420 14.020 14.100 3,424,480 14.2871
04 Jul 2019 13.880 14.360 13.880 14.240 4,494,000 14.2358
03 Jul 2019 13.700 14.140 13.500 13.900 4,603,621 13.8628
02 Jul 2019 13.840 13.880 13.600 13.760 3,816,660 13.7223
28 Jun 2019 13.900 13.980 13.140 13.420 6,563,509 13.4437
27 Jun 2019 13.700 13.940 13.440 13.900 8,220,112 13.7583
26 Jun 2019 13.100 13.780 13.100 13.500 3,494,500 13.5655
25 Jun 2019 13.000 13.360 13.000 13.140 2,769,801 13.1552
24 Jun 2019 13.000 13.340 12.900 13.240 1,714,270 13.2137
21 Jun 2019 13.500 13.500 12.840 13.140 5,138,781 13.1018
20 Jun 2019 13.180 13.600 13.020 13.540 3,045,752 13.4283
19 Jun 2019 13.400 13.400 13.020 13.180 6,803,537 13.1714
Summary
Current 2 Weeks
(08 Jul 2019 to 19 Jul 2019)
14.100 14.360 13.220 13.600 56,135,410 -
Previous 2 Weeks
(21 Jun 2019 to 05 Jul 2019)
13.500 14.360 12.840 14.100 44,239,734 -
4 Weeks from
(23 May 2019 to 20 Jun 2019)
13.740 14.360 13.080 13.540 121,272,025 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.